Developing Better Drugs for Pulmonary Sarcoidosis: Determining Indications for Treatment and Endpoints to Assess Therapy Based on Patient and Clinician Concerns

F1000Research - United Kingdom
doi 10.12688/f1000research.20696.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

Sarcoidosis Developing During Therapy for Breast Cancer

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1986English

Indications for Treatment in Pulmonary Tuberculosis

BMJ
1930English

Pulmonary Embolism Developing During Thalidomide Therapy for Multiple Myeloma in a Hemodialysis Patient

Nihon Toseki Igakkai Zasshi
2011English

Sarcoidosis: Patient Treatment Priorities

ERJ Open Research
PulmonaryRespiratory Medicine
2018English

Patient Treatment in ED Hallways and Patient Perception of Clinician-Patient Communication

American Journal of Emergency Medicine
MedicineEmergency Medicine
2016English

Can Pulmonary Vasodilator Therapy Expand the Operative Indications for Congenital Heart Disease?

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

Examining the Impact of Patient-Reported Hope for Improvement and Patient Satisfaction With Clinician/Treatment on the Outcome of Major Depressive Disorder Treatment

International Neuropsychiatric Disease Journal
2016English

Prostacyclin and Oral Vasodilator Therapy in Sarcoidosis-Associated Pulmonary Hypertension

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2015English

Establishment of a Method to Analyze Drugs in the Hair and Its Application for Determining Patient Compliance.

Folia Pharmacologica Japonica
Pharmacology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy